Search results for "emitting"

showing 10 items of 250 documents

Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis

2017

Abstract The therapeutic mode of action of dimethyl fumarate (DMF), approved for treating patients with relapsing-remitting multiple sclerosis, is not fully understood. Recently, we and others demonstrated that Ab-independent functions of distinct B cell subsets are important in mediating multiple sclerosis (MS) relapsing disease activity. Our objective was to test whether and how DMF influences both the phenotype and functional responses of disease-implicated B cell subsets in patients with MS. High-quality PBMC were obtained from relapsing-remitting MS patients prior to and serially after initiation of DMF treatment. Multiparametric flow cytometry was used to monitor the phenotype and fun…

AdultMale0301 basic medicineDimethyl FumarateImmunologyNaive B cellB-Lymphocyte SubsetsEnzyme-Linked Immunosorbent AssayBiologyPeripheral blood mononuclear cellProinflammatory cytokineFlow cytometryYoung Adult03 medical and health scienceschemistry.chemical_compoundMultiple Sclerosis Relapsing-Remitting0302 clinical medicineIn vivomedicineHumansImmunology and AllergyB cellmedicine.diagnostic_testDimethyl fumarateMultiple sclerosisMiddle AgedFlow Cytometrymedicine.disease030104 developmental biologymedicine.anatomical_structurechemistryImmunologyCancer researchFemaleImmunosuppressive Agents030217 neurology & neurosurgeryThe Journal of Immunology
researchProduct

Application of tRNS to improve multiple sclerosis fatigue: a pilot, single-blind, sham-controlled study

2019

We evaluated the effects of transcranial random noise stimulation (tRNS) on fatigue in 17 subjects with relapsing–remitting multiple sclerosis with low physical disability. Two different patient groups underwent real or sham stimulation for 10 days, targeting the primary motor cortex of the dominant side or contralateral to the most compromised limb. In the ‘real group’, beneficial effects were observed using the Modified Fatigue Impact Scale (p = 0.04; physical subscale: p = 0.03), the subscales ‘change in health’ (p = 0.006) and ‘role limitations due to physical problems’ (p = 0.001) of the Multiple Sclerosis Quality of Life-54, and by assessing the patient impression of perceived fatigue…

AdultMale0301 basic medicinemedicine.medical_specialtyPhysical disabilityNeurologyFatigue treatmentStimulationTranscranial Direct Current StimulationSeverity of Illness IndexPlacebosYoung Adult03 medical and health sciencesMultiple Sclerosis Relapsing-Remitting0302 clinical medicinePhysical medicine and rehabilitationOutcome Assessment Health CaremedicineHumansMultiple sclerosiSingle-Blind MethodBeneficial effectsFatigueBiological Psychiatrybusiness.industryMSQoL-54Multiple sclerosisMotor CortextRNSmedicine.diseaseFatigue impact scalePsychiatry and Mental health030104 developmental biologyPrimary motor areaNeurologyQuality of LifeFemaleMFISNeurology (clinical)Single blindPrimary motor cortexbusiness030217 neurology & neurosurgeryJournal of Neural Transmission
researchProduct

Moral Cognition and Multiple Sclerosis: A Neuropsychological Study

2017

Objectives Recent literature proved that social cognition impairments may characterize the neuropsychological profile of Multiple Sclerosis (MS) patients. However, little is still known about moral cognition in MS. In this study, we evaluated non-social, social, and moral cognitive performances in 45 relapsing-remitting MS patients. Methods Patients underwent the Brief International Cognitive Assessment for Multiple Sclerosis battery, the Cognitive Estimation and Stroop tasks, the Ekman-60 Faces test, the Reading the Mind in the Eye and Story-based Empathy task. Additionally, a task of moral dilemmas including both "instrumental" and "incidental" conditions was administered to patients. For…

AdultMale050103 clinical psychologymedia_common.quotation_subjectMoral cognitionEmotionsTheory of MindMoral judgmentEmpathyNeuropsychological TestsMoralsMultiple sclerosisJudgmentYoung AdultCognitionMultiple Sclerosis Relapsing-RemittingSocial cognitionTheory of mindmedicineHumans0501 psychology and cognitive scienceshealth care economics and organizationsmedia_commonEmotions/emotional processing05 social sciencesNeuropsychologyCognitionGeneral MedicineEmotional detachmenthumanitiesPsychiatry and Mental healthClinical PsychologyNeuropsychology and Physiological PsychologyCase-Control StudiesFemaleSettore MED/26 - Neurologiamedicine.symptomEmpathyPsychologyAttributionStroop effectClinical psychology
researchProduct

Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS

2020

ObjectiveTo assess the impact of laquinimod treatment on monocytes and to investigate the underlying immunomodulatory mechanisms in MS.MethodsIn this cross-sectional study, we performed in vivo and in vitro analyses of cluster of differentiation (CD14+) monocytes isolated from healthy donors (n = 15), untreated (n = 13), and laquinimod-treated patients with MS (n = 14). Their frequency and the expression of surface activation markers were assessed by flow cytometry and the viability by calcein staining. Cytokine concentrations in the supernatants of lipopolysaccharide (LPS)-stimulated monocytes were determined by flow cytometry. The messenger ribonucleic acid (mRNA) expression level of gene…

AdultMale41Lipopolysaccharide[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyCD14medicine.medical_treatmentInterleukin-1betaQuinolonesLymphocyte ActivationMonocytesArticleFlow cytometrychemistry.chemical_compoundMultiple Sclerosis Relapsing-RemittingDownregulation and upregulationmedicineHumansCD86medicine.diagnostic_testbusiness.industry[SDV.NEU.NB] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyInterleukin[SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/ImmunotherapyMiddle AgedMolecular biologyCross-Sectional StudiesCytokineNeurologychemistryTh17 CellsFemaleNeurology (clinical)[SDV.IMM.IMM] Life Sciences [q-bio]/Immunology/ImmunotherapybusinessLaquinimodSignal TransductionNeurology - Neuroimmunology Neuroinflammation
researchProduct

Evidence for early, non-lesional cerebellar damage in patients with multiple sclerosis: DTI measures correlate with disability, atrophy, and disease …

2015

Background: Common symptoms of multiple sclerosis (MS) such as gait ataxia, poor coordination of the hands, and intention tremor are usually the result of dysfunctionality in the cerebellum. Magnetic resonance imaging (MRI) has frequently failed to detect cerebellar damage in the form of inflammatory lesions in patients presenting with symptoms of cerebellar dysfunction. Objective: To detect microstructural cerebellar tissue alterations in early MS patients with a “normal appearing” cerebellum using diffusion tensor imaging (DTI). Methods: A total of 68 patients with relapsing–remitting MS (RRMS) and without cerebellar lesions and 26 age-matched healthy controls were admitted to high-resolu…

AdultMaleCerebellumPathologymedicine.medical_specialtyTime FactorsSeverity of Illness Index030218 nuclear medicine & medical imagingYoung Adult03 medical and health sciencesMultiple Sclerosis Relapsing-Remitting0302 clinical medicineAtrophyCerebellar DiseasesFractional anisotropymedicineHumansmedicine.diagnostic_testMultiple sclerosisMagnetic resonance imagingMiddle Agedmedicine.diseaseWhite MatterDiffusion Tensor Imagingmedicine.anatomical_structurenervous systemNeurologyGait AtaxiaFemaleIntention tremorNeurology (clinical)Atrophymedicine.symptomPsychology030217 neurology & neurosurgeryDiffusion MRIMultiple Sclerosis Journal
researchProduct

Gray matter network reorganization in multiple sclerosis from 7‐Tesla and 3‐Tesla MRI data

2020

[Objective]: The objective of this study was to determine the ability of 7T‐MRI for characterizing brain tissue integrity in early relapsing‐remitting MS patients compared to conventional 3T‐MRI and to investigate whether 7T‐MRI improves the performance for detecting cortical gray matter neurodegeneration and its associated network reorganization dynamics.

AdultMaleDYNAMICS0301 basic medicineNeurosciences. Biological psychiatry. NeuropsychiatryBrain tissueATROPHYYoung Adult03 medical and health sciencesMultiple Sclerosis Relapsing-Remitting0302 clinical medicineText miningAtrophymedicineHumans3 TGray MatterRC346-429Research ArticlesCerebral CortexCHALLENGESbusiness.industryDISABILITYGeneral NeuroscienceMultiple sclerosisMiddle AgedTissue repairmedicine.diseaseMagnetic Resonance ImagingWhite Matter030104 developmental biologyHealthy individualsFemaleNeurology. Diseases of the nervous systemNeurology (clinical)Nerve NetbusinessNuclear medicine030217 neurology & neurosurgeryRC321-571Research ArticleAnnals of Clinical and Translational Neurology
researchProduct

Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis

2003

Objective: Wallerian degeneration in normal appearing white matter in early relapsing-remitting multiple sclerosis (RRMS), and its correlation with the number of relapses and disease duration. Background Recent pathological studies have demonstrated Wallerian degeneration in normal appearing white matter (NAWM) in multiple sclerosis (MS), in established RRMS, and in chronic MS. However, the presence of Wallerian degeneration early in the disease and its correlation with relapse and with disease duration has not been studied. Methods: We performed proton magnetic resonance spectroscopic imaging in 21 MS patients, and 4 healthy controls, age and gender matched, aged under 45 years, with a max…

AdultMaleIn vivo magnetic resonance spectroscopyWallerian degenerationPathologymedicine.medical_specialtyMagnetic Resonance SpectroscopyTime FactorsNeurologyAdolescentWhite matterCentral nervous system diseaseMultiple Sclerosis Relapsing-RemittingmedicineHumansAspartic AcidMultiple sclerosisBrainmedicine.diseaseMagnetic Resonance ImagingPonsRadiographymedicine.anatomical_structurenervous systemNeurologyCerebellar peduncleCreatinineFemaleNeurology (clinical)Wallerian DegenerationPsychologyJournal of Neurology
researchProduct

Corpus callosum function in verbal dichotic listening: inferences from a longitudinal follow-up of Relapsing-Remitting Multiple Sclerosis patients.

2009

This study conducted a follow-up of 13 early-onset slightly disabled Relapsing-Remitting Multiple Sclerosis (RRMS) patients within an year, evaluating both CC area measurements in a midsagittal Magnetic Resonance (MR) image, and Dichotic Listening (DL) testing with stop consonant vowel (C-V) syllables. Patients showed a significant progressive loss of posterior CC areas (isthmus and splenium) related to increasing EDSS scores and an enhancing right ear advantage (REA) over time. A significant correlation between posterior CC areas and DL scores emerged in both evaluations, being negative for the right and positive for the left ear. The pattern of correlations suggests that the CC can serve …

AdultMaleLinguistics and Languagemedicine.medical_specialtyCognitive NeuroscienceSpleniumExperimental and Cognitive PsychologyAudiologyNeuropsychological TestsCorpus callosumSeverity of Illness IndexLanguage and LinguisticsFunctional LateralityDevelopmental psychologyCorpus CallosumSpeech and HearingYoung AdultMultiple Sclerosis Relapsing-RemittingStop consonantVowelProhibitinsmedicineHumansActive listeningAge of OnsetAnalysis of VarianceDichotic listeningPhonologyCognitionMagnetic Resonance ImagingAcoustic StimulationAuditory PerceptionDisease ProgressionFemalePsychologyFollow-Up StudiesBrain and language
researchProduct

Functional connectivity analysis using whole brain and regional network metrics in MS patients

2016

In the present study we investigated brain network connectivity differences between patients with relapsing-remitting multiple sclerosis (RRMS) and healthy controls (HC) as derived from functional resonance magnetic imaging (fMRI) using graph theory. Resting state fMRI data of 18 RRMS patients (12 female, mean age ± SD: 42 ± 12.06 years) and 25 HC (8 female, 29.2 ± 5.38 years) were analyzed. In order to obtain information of differences in entire brain network, we focused on both, local and global network connectivity parameters. And the regional connectivity differences were assessed using regional network parameters. RRMS patients presented a significant increase of modularity in comparis…

AdultMaleModularity (networks)Resting state fMRIInformation processingBrainCognitionSuperior parietal lobuleMiddle AgedMagnetic Resonance Imaging030218 nuclear medicine & medical imagingCorrelation03 medical and health sciencesMultiple Sclerosis Relapsing-Remitting0302 clinical medicineImage Processing Computer-AssistedHumansFemaleNerve NetPsychologyInsulaNeuroscience030217 neurology & neurosurgeryClustering coefficient2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
researchProduct

Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study

2022

Background and ObjectivesSeveral studies have assessed risk factors associated with the severity of COVID-19 outcomes in people with multiple sclerosis (PwMS). The potential role of disease-modifying therapies (DMTs) and demographic and clinical factors on the risk of acquiring SARS-CoV-2 infection has not been evaluated so far. The objective of this study was to assess risk factors of contracting SARS-CoV-2 infection in PwMS by using data collected in the Italian MS Register (IMSR).MethodsA case-control (1:2) study was set up. Cases included PwMS with a confirmed diagnosis of COVID-19, and controls included PwMS without a confirmed diagnosis of COVID-19. Both groups were propensity score–m…

AdultMaleMultiple SclerosisTime Factors41Dimethyl FumarateSex FactorRelapsing-RemittingSeverity of Illness IndexArticleImmunosuppressive AgentSex FactorsMultiple Sclerosis Relapsing-RemittingRisk FactorsMultiple SclerosiOdds RatioHumansAge Factor36053g COVID-19Fingolimod HydrochlorideSARS-CoV-2NatalizumabRisk FactorAge FactorsCOVID-19Glatiramer AcetateInterferon-betaMiddle AgedMultiple Sclerosis Chronic Progressive323Chronic ProgressiveNeurologyItalyCase-Control StudiesAdult; Age Factors; COVID-19; Case-Control Studies; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Italy; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis Chronic Progressive; Multiple Sclerosis Relapsing-Remitting; Natalizumab; Odds Ratio; Risk Factors; SARS-CoV-2; Severity of Illness Index; Sex Factors; Time FactorsFemaleNeurology (clinical)Case-Control StudieImmunosuppressive AgentsHuman
researchProduct